Jerry S. Lanchbury

2015

In 2015, Jerry S. Lanchbury earned a total compensation of $3.2M as Chief Scientific Officer at Myriad Genetics, a 22% increase compared to previous year.

Compensation breakdown

Bonus$614
Non-Equity Incentive Plan$207,423
Salary$470,000
Stock Awards$2,477,800
Other$10,110
Total$3,165,947

Lanchbury received $2.5M in stock awards, accounting for 78% of the total pay in 2015.

Lanchbury also received $614 in bonus, $207.4K in non-equity incentive plan, $470K in salary and $10.1K in other compensation.

Rankings

In 2015, Jerry S. Lanchbury's compensation ranked 2,978th out of 13,638 executives tracked by ExecPay. In other words, Lanchbury earned more than 78.2% of executives.

ClassificationRankingPercentile
All
2,978
out of 13,638
78th
Division
Manufacturing
1,051
out of 5,187
80th
Major group
Chemicals And Allied Products
387
out of 1,857
79th
Industry group
Drugs
302
out of 1,531
80th
Industry
In Vitro and In Vivo Diagnostic Substances
8
out of 76
90th
Source: SEC filing on October 12, 2017.

Lanchbury's colleagues

We found five more compensation records of executives who worked with Jerry S. Lanchbury at Myriad Genetics in 2015.

2015

Peter Meldrum

Myriad Genetics

Chief Executive Officer

2015

James Evans

Myriad Genetics

Chief Financial Officer

2015

Mark Capone

Myriad Genetics

Chief Executive Officer

2015

Richard Marsh

Myriad Genetics

General Counsel

2015

R Riggsbee

Myriad Genetics

Chief Financial Officer

News

You may also like